WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: CTX310

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on CTX310

Proof of use for CTX310

We do not have any records of a proof of use for CTX310 at this moment.

Click here to add a proof of use for CTX310

Possible trademark infringements of CTX310

Basic Information about CTX310

Serial Number
97461217
Filing Date
16 Jun 2022
Mark Drawing Code
4

Classifications

Declare the trademark use of CTX310 on the blockchain with WikiTrademarks.io.

First use of CTX310 anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052
First use of CTX310 anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns CTX310?

1. CRISPR Therapeutics AG ZUG V8 SWITZERLAND

2. CRISPR Therapeutics AG ZUG V8 SWITZERLAND

Correspondent

Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on CTX310